Abstract
Inhibition of aromatase activity in vitro is one of the Tier 1 screening assays proposed by the Endocrine Disrupter Screening and Testing Advisory Committee (EDSTAC) for the detection of potential endocrine disrupters. In this report a rat ovarian aromatase inhibition assay has been evaluated using the reference aromatase inhibitors anastrozole, fadrozole, letrozole and CGS 18320B. Rat ovary microsomes were used as the enzyme source, as endocrine disruption studies are most commonly carried out in this species. Aromatase activity was inhibited in vitro by anastrozole, fadrozole, letrozole and CGS 18320B with IC 50s of 25, 7, 7 and 5 nM, respectively. This assay, therefore, appears to have good sensitivity to aromatase inhibitors and may be useful as a general screening assay and in mechanistic studies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
